RegenETP, Inc.

RGTPQ

RGTPQRegenETP, Inc. US flag

OTC Markets EXMKT

0.15

USD

- -

-0.60EPS

-0.25P/E

1.11MMarket Cap

Mar 26Next Earn

RegenETP, Inc.

RGTPQ

(OTC Markets EXMKT)

Recent

price

0.15

P/E

ratio

-0.25

div

yld

- -

ROIC.AI

Legends:

Stock price

Beta (1.0 Market)

% total return 03/27

Stock

S&P500

638.92

10.92

-97.86

26.22

-99.52

120.31

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	TTM
2,239.91	2,435.18	3,331.41	2,145.68	3,414.67	3,474.93	1,193.01	802.9	136.23	- -	- -	2.56	5.66	6.53	2.94	0.12	0.01	Revenue per Share
-209.63	127.77	-253.56	-27.57	186.2	121.17	-319.08	-378.39	-123.36	-126.93	-666.84	-121.5	-92.62	-27.63	-9.43	-1.14	-1.27	Basic EPS, GAAP
-40.83	-114.81	-237.16	-94.11	243.98	151.15	-122.69	-90.08	-32.85	-21.06	-51.42	-61.87	-59.5	-25.2	-7.11	-3.3	-3.3	Free Cash Flow per Basic Share
- -	- -	- -	- -	- -	- -	- -	- -	- -	119.27	- -	- -	- -	- -	- -	- -	- -	Dividend per Share
-4,284.74	-3,588.41	-3,573.75	-2,901.46	-2,601.66	-2,386.35	-2,612.9	-2,796.87	-2,514.38	-1,528.78	-1,315.16	-531.51	-435.92	-308.25	-158.85	-75.33	-79.32	Book Value per Share
89.74	272.04	413.34	340.59	633.24	770.63	506.13	129.68	101.02	-56.73	-557.68	131.76	37.96	17.1	6.01	2.42	1.89	Tangible Book Value per Share
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	2	3	7	7	Basic Weighted Avg Shares
51	64	94	76	125	132	47	34	7	- -	- -	2	6	10	9	1	- -	Sales/Revenue/Turnover
-7.51	1.89	-5.51	-2.25	10.27	3.73	-22.82	-37.85	-46.11	- -	- -	-4,442.23	-1,652.39	-415.82	-344.3	-3,178.99	-29,868.49	Operating Margin (%)
3	6	14	7	7	18	7	11	- -	- -	- -	1	3	3	3	2	1	Depreciation Expense
-5	3	-7	-1	7	5	-13	-16	-4	-5	-131	-65	-92	-43	-30	-8	-8	Net Income, GAAP
- -	0.77	- -	- -	5.87	1.56	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Effective Tax Rate (%)
-9.36	5.25	-7.61	-1.28	5.45	3.49	-26.75	-47.13	-56.91	- -	- -	-4,186.88	-1,636.46	-423.21	-321	-962.29	-11,376.71	Profit Margin (%)
3	7	12	12	24	28	16	5	16	5	3	68	22	23	18	11	7	Working Capital
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	4	3	- -	3	2	LT Debt
3	7	12	12	23	29	20	6	16	5	5	82	39	27	19	17	12	Total Equity
- -	24.58	- -	- -	67.94	18.32	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Return on Invested Capital (%)
- -	-4.17	- -	- -	-8.1	-5.96	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Return on Capital (%)
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Return on Common Equity (%)

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	- -	33.13%	-91.34%
Net Income, GAAP	215.31%	-33.18%	-74.05%
Free Cash Flow	47.33%	50.75%	-0.52%
Total Cash Common Dividend	- -	- -	- -
Total Equity	150.79%	301.61%	-13.65%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Similar Companies: Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ)
Argenica Therapeutics Limited (AGN.AX)
Pharmicell Co., Ltd. (005690.KS)
Solid Biosciences Inc. (SLDB)
Patrys Limited (PAB.AX)
AnPac Bio-Medical Science Co., Ltd. (ANPC)
Business: RegenETP, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and other tissue regeneration products. The company was formerly known as PolarityTE, Inc. and changed its name to RegenETP, Inc. in August 2023. RegenETP, Inc. is headquartered in Salt Lake City, Utah.

Year	Q1	Q2	Q3	Q4	FY
2021	-5.72	-0.99	-0.31	- -	-9.43
2022	-1.12	-0.01	-0.47	- -	-1.14
2023	-0.58	- -	- -	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2021	5	3	1	1	9
2022	1	- -	- -	- -	1
2023	- -	- -	- -	- -	- -

	Sep'22	Dec'22	Mar'23
Total Current Assets	18	13	9
Accounts Receivable, Net	- -	- -	- -
Cash, Cash Equivalents & STI	16	11	6
Inventories	- -	- -	- -
Total Current Liabilities	3	2	2
Payables & Accruals	2	1	2
ST Debt	1	1	- -
Deferred Revenue	- -	- -	- -

	Sep'22	Dec'22	Mar'23
ST Debt	1	1	- -
LT Borrowings	- -	- -	- -
LT Finance Leases	- -	3	2
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	7	7	7
Market Capitalization	5	3	3

Year	Q1	Q2	Q3	Q4	FY
2021	- -	- -	- -	- -	- -
2022	- -	- -	- -	- -	- -
2023	- -	- -	- -	- -	- -

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	TTM
2,239.91	2,435.18	3,331.41	2,145.68	3,414.67	3,474.93	1,193.01	802.9	136.23	- -	- -	2.56	5.66	6.53	2.94	0.12	0.01	Revenue per Share
-209.63	127.77	-253.56	-27.57	186.2	121.17	-319.08	-378.39	-123.36	-126.93	-666.84	-121.5	-92.62	-27.63	-9.43	-1.14	-1.27	Basic EPS, GAAP
-40.83	-114.81	-237.16	-94.11	243.98	151.15	-122.69	-90.08	-32.85	-21.06	-51.42	-61.87	-59.5	-25.2	-7.11	-3.3	-3.3	Free Cash Flow per Basic Share
- -	- -	- -	- -	- -	- -	- -	- -	- -	119.27	- -	- -	- -	- -	- -	- -	- -	Dividend per Share
-4,284.74	-3,588.41	-3,573.75	-2,901.46	-2,601.66	-2,386.35	-2,612.9	-2,796.87	-2,514.38	-1,528.78	-1,315.16	-531.51	-435.92	-308.25	-158.85	-75.33	-79.32	Book Value per Share
89.74	272.04	413.34	340.59	633.24	770.63	506.13	129.68	101.02	-56.73	-557.68	131.76	37.96	17.1	6.01	2.42	1.89	Tangible Book Value per Share
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	2	3	7	7	Basic Weighted Avg Shares
51	64	94	76	125	132	47	34	7	- -	- -	2	6	10	9	1	- -	Sales/Revenue/Turnover
-7.51	1.89	-5.51	-2.25	10.27	3.73	-22.82	-37.85	-46.11	- -	- -	-4,442.23	-1,652.39	-415.82	-344.3	-3,178.99	-29,868.49	Operating Margin (%)
3	6	14	7	7	18	7	11	- -	- -	- -	1	3	3	3	2	1	Depreciation Expense
-5	3	-7	-1	7	5	-13	-16	-4	-5	-131	-65	-92	-43	-30	-8	-8	Net Income, GAAP
- -	0.77	- -	- -	5.87	1.56	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Effective Tax Rate (%)
-9.36	5.25	-7.61	-1.28	5.45	3.49	-26.75	-47.13	-56.91	- -	- -	-4,186.88	-1,636.46	-423.21	-321	-962.29	-11,376.71	Profit Margin (%)
3	7	12	12	24	28	16	5	16	5	3	68	22	23	18	11	7	Working Capital
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	4	3	- -	3	2	LT Debt
3	7	12	12	23	29	20	6	16	5	5	82	39	27	19	17	12	Total Equity
- -	24.58	- -	- -	67.94	18.32	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Return on Invested Capital (%)
- -	-4.17	- -	- -	-8.1	-5.96	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Return on Capital (%)
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Return on Common Equity (%)

RegenETP, Inc.

Growth Rates

(avg. rate of change)

Growth Rates

(avg. rate of change)

Quarterly Earnings Per Share

Year

Quarterly Revenue

Year

Working Capital

Capital Structure

Quarterly Dividends Per Share

Year